Furthermore, it has been found that elimination of Schwann cell TRPA1 attenuates lung cancer-induced mechanical allodynia, and therefore, Schwann cell TRPA1 may represent a potential target for the treatment of cancer pain (De Logu et al. 2021a). Here, TRPA1 is linked to lung carcinoma.